...
首页> 外文期刊>Clinical and applied thrombosis/hemostasis : >Prevalence of Autoantibodies Related to Some Autoimmune Disorders in Patients With Chronic Idiopathic Thrombocytopenic Purpura
【24h】

Prevalence of Autoantibodies Related to Some Autoimmune Disorders in Patients With Chronic Idiopathic Thrombocytopenic Purpura

机译:慢性特发性血小板减少性紫癜患者与某些自身免疫性疾病相关的自身抗体的流行

获取原文
   

获取外文期刊封面封底 >>

       

摘要

We investigated the prevalence of antinuclear antibody (ANA), thyroid antimicrosomal (AMA) and antithyroglobulin (ATA), antigliadin (AGA) immunoglobulin G (IgG)-A, anti-endomisium (EMA) IgG-A, and tissue transglutaminase (tTG) IgG-A in 87 patients with chronic idiopathic thrombocytopenic purpura (cITP) and in 95 healthy controls. Antinuclear antibody positivity was found in 13 of 87 patients and 3 of 95 controls (P = .007). Antithyroglobulin positivity was found in 27 of patients and in 7 of the controls (P .001). AMA positivity was found in 20 of patients and 8 of the controls (P = 0.008). Antigliadin IgG was positive in 17 patients and 1 controls (P .001) whereas Antigliadin IgA was positive in 9 of patients and in 1 of the controls (P = .007). Anti-endomisium (IgG and IgA were not different between both groups. Tissue transglutaminase IgG was detected in 7 of patients and in 1 of the controls (P = .029). Tissue transglutaminase IgA was detected in 5 of patients and in none of the controls (P = .023). We believe that larger studies are needed to determine the long-term impact and clinical importance of these autoantibodies.
机译:我们调查了抗核抗体(ANA),甲状腺抗微粒体(AMA)和抗甲状腺球蛋白(ATA),抗gliadin(AGA)免疫球蛋白G(IgG)-A,抗内膜(EMA)IgG-A和组织转谷氨酰胺酶(tTG)的患病率IgG-A在87例慢性特发性血小板减少性紫癜(cITP)患者中和95个健康对照中。在87名患者中的13名和95名对照中的3名中发现了抗核抗体阳性(P = .007)。在27例患者和7例对照中发现抗甲状腺球蛋白阳性(P <.001)。在20例患者和8例对照中发现AMA阳性(P = 0.008)。 Antigliadin IgG在17例患者和1个对照组中呈阳性(P <.001),而Antigliadin IgA在9例患者和1个对照组中呈阳性(P = .007)。两组之间的抗内膜内分泌(IgG和IgA均无差异。在7例患者和1个对照组中检测到组织转谷氨酰胺酶IgG(P = .029)。在5例患者中检测到组织转谷氨酰胺酶IgA,但均未检测到。对照(P = .023)。我们认为,需要进一步的研究来确定这些自身抗体的长期影响和临床重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号